ZNF487
gene geneOn this page
Summary
ZNF487 (zinc finger protein 487, HGNC:23488) is a protein-coding gene on chromosome 10q11.21, encoding Zinc finger protein 487 (B1APH4). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 642819 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- MANE Select transcript:
NM_001355444
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23488 |
| Approved symbol | ZNF487 |
| Name | zinc finger protein 487 |
| Location | 10q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000243660 |
| Ensembl biotype | protein_coding |
| Entrez | 642819 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 19 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000315429, ENST00000437590, ENST00000451167, ENST00000456416, ENST00000490208, ENST00000596267, ENST00000652684, ENST00000689627, ENST00000887192, ENST00000887193, ENST00000887194, ENST00000887195, ENST00000887196, ENST00000887197, ENST00000887198, ENST00000887199, ENST00000887200, ENST00000941780, ENST00000941781, ENST00000941782, ENST00000941783
RefSeq mRNA: 7 — MANE Select: NM_001355444
NM_001355444, NM_001355445, NM_001355446, NM_001355447, NM_001355448, NM_001355449, NM_001355450
CCDS: CCDS86084
Canonical transcript exons
ENST00000437590 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001463537 | 43481429 | 43483181 |
| ENSE00002514680 | 43476107 | 43476202 |
| ENSE00003487507 | 43475721 | 43475847 |
| ENSE00003924620 | 43437111 | 43437262 |
Expression profiles
Bgee: expression breadth ubiquitous, 223 present calls, max score 94.45.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.8897 / max 59.4992, expressed in 1215 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 104756 | 1.8637 | 790 |
| 104757 | 1.0260 | 531 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 94.45 | gold quality |
| bronchus | UBERON:0002185 | 93.45 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 91.45 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 90.79 | gold quality |
| right uterine tube | UBERON:0001302 | 87.80 | gold quality |
| left testis | UBERON:0004533 | 87.42 | gold quality |
| right testis | UBERON:0004534 | 87.40 | gold quality |
| oviduct epithelium | UBERON:0004804 | 85.98 | gold quality |
| testis | UBERON:0000473 | 85.51 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 82.48 | gold quality |
| nasopharynx | UBERON:0001728 | 82.47 | gold quality |
| corpus epididymis | UBERON:0004359 | 82.16 | gold quality |
| oocyte | CL:0000023 | 82.12 | gold quality |
| sperm | CL:0000019 | 81.50 | gold quality |
| caput epididymis | UBERON:0004358 | 81.12 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.06 | gold quality |
| fallopian tube | UBERON:0003889 | 81.04 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 80.92 | gold quality |
| monocyte | CL:0000576 | 80.81 | gold quality |
| leukocyte | CL:0000738 | 80.48 | gold quality |
| sural nerve | UBERON:0015488 | 79.93 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.71 | gold quality |
| blood | UBERON:0000178 | 79.41 | gold quality |
| ventricular zone | UBERON:0003053 | 79.33 | gold quality |
| bone marrow cell | CL:0002092 | 79.27 | gold quality |
| caudate nucleus | UBERON:0001873 | 78.49 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.44 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.38 | gold quality |
| hypothalamus | UBERON:0001898 | 78.31 | gold quality |
| adenohypophysis | UBERON:0002196 | 77.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.24 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)
Protein
Protein identifiers
Zinc finger protein 487 — B1APH4 (reviewed: B1APH4)
Alternative names: KRAB domain only protein 1
All UniProt accessions (4): B1APH4, A0A494C0H0, B2REC8, H0Y2R6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (7): NP_001342373, NP_001342374, NP_001342375, NP_001342376, NP_001342377, NP_001342378, NP_001342379 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
UniProt features (4 total): chain 1, domain 1, zinc finger region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B1APH4-F1 | 37.79 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, OSMAN_BLADDER_CANCER_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CIITA_TARGET_GENES, FOXJ2_TARGET_GENES, FOXN3_TARGET_GENES, HOXA10_TARGET_GENES, ZSCAN31_TARGET_GENES, SAFB2_TARGET_GENES, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_MUSCLE_MEGAKARYOCYTES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
188 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF487 | OR4F21 | O95013 | 581 |
| ZNF487 | GARIN5A | Q6IPT2 | 570 |
| ZNF487 | ZNF772 | Q68DY9 | 512 |
| ZNF487 | H7C0V5 | H7C0V5 | 507 |
| ZNF487 | RNF208 | Q9H0X6 | 475 |
| ZNF487 | ZBTB45 | Q96K62 | 447 |
| ZNF487 | M0QY95 | M0QY95 | 447 |
| ZNF487 | ZNF212 | Q9UDV6 | 446 |
| ZNF487 | ZNF816 | Q0VGE8 | 444 |
| ZNF487 | ZNF200 | P98182 | 444 |
| ZNF487 | SWSAP1 | Q6NVH7 | 432 |
| ZNF487 | ZNF791 | Q3KP31 | 431 |
| ZNF487 | ZNF101 | Q8IZC7 | 417 |
| ZNF487 | KLHDC7B | Q96G42 | 400 |
| ZNF487 | ZNF488 | Q96MN9 | 377 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ECE1 | ZNF487 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0JPL0, A1KXM5, A3CEM4, A6NK53, A7KBS4, A7MBI1, A8K554, A8MT65, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E7ETH6, E9Q8G5, F4KIH4, G3X9G7, O14628, P0CH99, P0CI00, P18853, Q32L17, Q3MJ40, Q3URS2, Q49AA0, Q4V8E9, Q5EBM4, Q5FWF6, Q5RE50, Q5REN4, Q6V9R5, Q6ZN11, Q6ZN79, Q755V9, Q80VJ6, Q86TJ5, Q8BGV5, Q8N535, Q8N720, Q8N859, Q8NC26
Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1382 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000049425 (10:43451844 C>T), RS1000128833 (10:43449251 A>G), RS1000154188 (10:43485361 A>C), RS1000158832 (10:43498697 C>T), RS1000182728 (10:43435424 G>C), RS1000285556 (10:43456849 G>A), RS1000367180 (10:43462576 C>T), RS1000409562 (10:43441245 A>C), RS1000435912 (10:43462763 T>A,C), RS1000442527 (10:43482059 C>A), RS1000454411 (10:43492127 T>C), RS1000545827 (10:43477314 C>T), RS1000549815 (10:43455593 G>A), RS1000560959 (10:43457789 G>A), RS1000569973 (10:43442593 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008891_10 | Cognitive performance (processing speed) | 4.000000e-06 |
| GCST90002400_703 | Plateletcrit | 6.000000e-14 |
| GCST90002402_115 | Platelet count | 6.000000e-12 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004363 | information processing speed |
| EFO:0007985 | platelet crit |
| EFO:0004309 | platelet count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, decreases expression, increases abundance | 1 |
| beta-lapachone | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| methacrylaldehyde | affects cotreatment, decreases expression, increases abundance | 1 |
| pentanal | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Acrolein | decreases expression, increases abundance, affects cotreatment | 1 |
| Air Pollutants | affects cotreatment, decreases expression, increases abundance | 1 |
| Ethanol | affects cotreatment, increases expression | 1 |
| Folic Acid | increases expression, affects cotreatment | 1 |
| Ozone | affects cotreatment, decreases expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Gold Compounds | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Volatile Organic Compounds | decreases expression, affects cotreatment | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.